RECURRENT LYMPHOBLASTIC LYMPHOMA

Clinical trials for RECURRENT LYMPHOBLASTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT LYMPHOBLASTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for RECURRENT LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Triple-Target immune therapy enters human trials for aggressive blood cancers

Disease control Recruiting now

This early-stage trial is testing the safety and best dose of a new type of CAR-T cell therapy designed to attack three different proteins (CD19, CD20, and CD22) found on cancer cells. It is for adults with certain aggressive blood cancers like non-Hodgkin lymphoma, acute lymphob…

Matched conditions: RECURRENT LYMPHOBLASTIC LYMPHOMA

Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

RECURRENT LYMPHOBLASTIC LYMPHOMA

Get alerted when new RECURRENT LYMPHOBLASTIC LYMPHOMA trials appear

New Triple-Target immune therapy enters human trials for aggressive blood cancers